SINGAPORE – Singapore’s newest attraction is no theme park or resort, but an under-construction tech park in the country’s north-eastern tip. Punggol Digital District (PDD) may not be slated ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

FARGO, N.D. (Valley News Live) - The Cass County Sheriff’s Office has begun use of the Flock Safety platform. It includes automatic license plate readers and high-definition cameras to assist ...

Bauxite is back in the spotlight. With prices skyrocketing 60% in just four months, ABx Group (ASX:ABX) is seizing the moment. Managing Director Mark Cooksey joins Mining.com.au to break down why ...

In public social media posts, the bird owners said a wild duck and her three ducklings appeared on the property before the flock got sick. While the owners tried to scare the wild ducks off ...

A bet on the relative performance of US interest rate swaps versus Treasuries is being dubbed the ‘trade of the year’ by macro funds, fuelled by comments from Federal Reserve officials on a possible ...

A new survey suggests that Dubai's population growth is having a negative impact on expat salaries. As more expats compete for jobs, salaries are set to remain flat in 2025, Cooper Fitch found ...

“Rebel With a Clause” celebrates the improbable cross-country journey of a woman who gently imparts grammar rules to strangers. Ellen Jovin, wearing a “Grammar Is Groovy” T-shirt, is the ...

ABx Group (ASX:ABX) is in talks with several parties regarding offtake, direct investment, and the possible purchasing of an asset for its Binjour and Taralga bauxite deposits in Queensland and New ...

February marked US bonds’ best monthly returns since July 2024. It was not smooth sailing, though. Inflation data released in mid-February came in higher than expected, slowing down the timeline ...

Centauri Therapeutics Limited has announced the selection of its first clinical candidate for the ABX-01 programme. The compound is designed to target serious Gram-negative bacterial lung infections.